13 Aug 2018

Future Medicinal Chemistry

Authors: Matthew A Sellwood, Mohamed Ahmed, Marwin HS Segler & Nathan Brown


There has been a great deal of hype surrounding the resurgence of Artificial Intelligence and Machine Learning. This commentary was published in Future Medicinal Chemistry as a brief overview of the AI and ML domains, their relevance in different aspects of drug discovery and, importantly, reflecting on managing expectations from different quarters. The key themes covered are molecular design approaches, including our recent paper on de novo design models, predictive modelling, synthesis planning, and closing the feedback loop to learn from our decisions.

Back to publications

Latest publications

09 Oct 2023
Learning the kernel for rare variant genetic association test
Read more
24 Aug 2023
Associating biological context with protein-protein interactions through text mining at PubMed scale
Read more
07 Dec 2022
NeurIPS 2022
sEHR-CE: Language modelling of structured EHR data for efficient and generalizable patient cohort expansion
Read more